-
-
Toggle navigation
Frontiers reaches 6.4 on Journal Impact Factors
Submit your manuscript
Scope
Nanobiotechnology has a broad field of appeal, from organ-on-chip technologies to nanobiosensors, from nanodiagnostics to advanced characterisation and imaging tools, from intelligent drug delivery to artificial bioconstructs, and from functional nanostructured surfaces to smart materials and nanofluidics.
Scope
The exploitation of nanotechnology in the development of biomedical devices allows the control of biological entities at previously unreachable levels, down to the single molecule. Living matter, manipulated at the nanoscale, can be thus technologically quantified, controlled, and engineered, for plenty of applications that range from diagnosis and treatment of pathologies to the preparation of nanostructured scaffolds for regenerative medicine purposes.
The technological/biological impact of nanoscale systems, the synthesis and the characterization of nanoscale biomaterials, and the innovative applications of “smart” nanoparticles are just some examples of the driving force of the specialty section “Nanobiotechnology”, within a robust multidisciplinary framework that needs contribution from engineering, chemistry, life science, and materials science.
Nanobiotechnology has a broad field of appeal, from organ-on-chip technologies to nanobiosensors, from nanodiagnostics to advanced characterisation and imaging tools, from intelligent drug delivery to artificial bioconstructs, and from functional nanostructured surfaces to smart materials and nanofluidics. Among all these topics, also nanotoxicology and possible harmful impact of nanomaterials in living organisms should be mentioned: the evaluation of the safety of an innovative nanodevice is, in fact, a process that should start since the very first steps of its concept and design. Particular attention is finally dedicated to the translational and regulatory aspects of nanobiomedical devices, envisioning their practical applications in the future clinical practice.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Semantic Scholar, Ulrich's Periodicals Directory, CLOCKSS, EI Compendex, OpenAIRE, Zetoc
PMCID: all published articles receive a PMCID
Nanobiotechnology welcomes submissions of the following article types: Book Review, Brief Research Report, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Nanobiotechnology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Nanobiotechnology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Bioengineering and Biotechnology and Molecular Biosciences.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01